Change in ischemia-modified albumin and its clinical significance during exercise stress testing

Circulation Journal

Volumn 74, Issue 3, 2010, Pages 484-489

  Lee, Dong Hyeon ^a   Jeon, Hui Kyung ^a   Park, Hun Jun ^a   Shin, Woo Seung ^a   Lee, Seung Won ^a   Youn, Ho Joong ^a   Kim, Chul Min ^a   Lee, Hae Kyung ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Exercise stress test; Ischemia modified albumin; Myocardial ischemia

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DYSPNEA; EXERCISE TEST; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTOR VARIABLE; THORAX PAIN; TREADMILL;

ADULT; AGED; BIOLOGICAL MARKERS; CHEST PAIN; DYSPNEA; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX;

EID: 77649199439     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0581     Document Type: Article

References (27)

1. McCraig LF, Burts CW. National Hospital Ambulatory Medical Care Survey: 2002 Emergency Department Summary. Adv Data 2004; 340: 1-34.
2. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, et al. Missed diagnosis of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 32: 1163-1170.
3. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF, et al. ACC/AHA guidelines for exercise testing: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30: 260-311.
4. Sketch MH, Mohiuddin SM, Nair CK, Mooss AN, Runco V. Automated and nomographic analysis of exercise tests. JAMA 1980; 243: 1052-1055.
5. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: A preliminary report. J Emerg Med 2000; 19: 311-315.
6. Bar-Or D, Curtis G, Rao N, Bampos N, Lau E. Characterization of the Co(2+) and Ni(2+) binding amino-acid residues of the N-terminus of human albumin: An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001; 268: 42-47.
7. Wu AH. The ischemia-modified albumin biomarker for myocardial ischemia. MLO Med Lab Obs 2003; 35: 36-40.
8. Bar-Or D, Winkler JV, Vanbenthuysen K, Harris L, Lau E, Hetzel FW. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 2001; 141: 985-991.
9. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003; 107: 2403-2405.
10. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of ballooninduced myocardial ischemia. Am J Cardiol 2003; 92: 322-324.
11. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol 2004; 93: 88-90.
12. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, et al. Characteristics of an albumin binding test for assessment of acute coronary syndrome patients: A multicenter study. Clin Chem 2001; 47: 464-470.
13. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003; 49: 581-585.
14. Sinha MK, Roy D, Gaze DC, Collinson PO, Kaski JC. Role of "ischemia-modified albumin", a new biochemical marker of myocardial ischemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004; 21: 29-34.
15. Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991; 325: 849-853.
16. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focused Update of the ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008; 117: 261-295.
17. + cells after myocardial infarction treated by bare metal stent implantation. Circ J 2008; 72: 897-901.
18. 2 is more potent than B-type natriuretic peptide as a prognostic parameter in cardiac patients. Circ J 2008; 72: 575-581.
19. Yamamoto M, Maeda H, Hirose N, Yamamoto M, Nakagawa A, Radhakrishnan G, et al. Biphasic elevation of bilirubin oxidation during myocardial ischemia reperfusion. Circ J 2008; 72: 1520-1527.
20. Chu S, Ding W, Li K, Pang Y, Tang C. Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ J 2008; 72: 1249-1253.
21. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002; 48: 1097-1100.
22. Zapico-Muniz E, Santalo-Bel M, Merce-Muntanola J, Montiel JA, Martinez-Rubio A, Ordonez-Llanos J. Ischemia modified albumin during skeletal muscle ischemia. Clin Chem 2004; 50: 1063-1065.
23. Roy D, Quiles J, Sharma R, Sinha M, Avanzas P, Gaze D, et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004; 50: 1656-1660.
24. van der Zee PM, Verberne HJ, van Straalen JP, Sanders GT, Van Eck-Smit BL, de Winter RJ, et al. Ischemia modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 2005; 51: 1744-1746.
25. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 2006; 48: 2482-2484.
26. Kurz K, Voelker R, Zdunek D, Wergeland R, Hess G, Ivandic B, et al. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol 2007; 96: 152-159.
27. Garrido IP, Roy D, Calviño R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, et al. Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 2004; 93: 88-90.